RU2019113064A3 - - Google Patents

Download PDF

Info

Publication number
RU2019113064A3
RU2019113064A3 RU2019113064A RU2019113064A RU2019113064A3 RU 2019113064 A3 RU2019113064 A3 RU 2019113064A3 RU 2019113064 A RU2019113064 A RU 2019113064A RU 2019113064 A RU2019113064 A RU 2019113064A RU 2019113064 A3 RU2019113064 A3 RU 2019113064A3
Authority
RU
Russia
Application number
RU2019113064A
Other versions
RU2019113064A (ru
RU2765102C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2019113064A publication Critical patent/RU2019113064A/ru
Publication of RU2019113064A3 publication Critical patent/RU2019113064A3/ru
Application granted granted Critical
Publication of RU2765102C2 publication Critical patent/RU2765102C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4453Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/104Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/108Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F11/00Compounds containing elements of Groups 6 or 16 of the Periodic Table

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
RU2019113064A 2016-09-30 2017-09-29 1-фенилпропаноновые соединения и их применение RU2765102C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102016000098338 2016-09-30
IT102016000098338A IT201600098338A1 (it) 2016-09-30 2016-09-30 Composti 1-fenilpropanone e loro impiego
PCT/IB2017/056010 WO2018060947A1 (en) 2016-09-30 2017-09-29 1-phenylpropanone compounds and use thereof

Publications (3)

Publication Number Publication Date
RU2019113064A RU2019113064A (ru) 2020-10-30
RU2019113064A3 true RU2019113064A3 (ru) 2020-10-30
RU2765102C2 RU2765102C2 (ru) 2022-01-25

Family

ID=57960639

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019113064A RU2765102C2 (ru) 2016-09-30 2017-09-29 1-фенилпропаноновые соединения и их применение

Country Status (19)

Country Link
US (1) US11345673B2 (ru)
EP (1) EP3518927B9 (ru)
JP (1) JP7016370B2 (ru)
CN (1) CN110035753B (ru)
AU (1) AU2017335421A1 (ru)
BR (1) BR112019006565A2 (ru)
CA (1) CA3038008A1 (ru)
DK (1) DK3518927T3 (ru)
ES (1) ES2830749T3 (ru)
HR (1) HRP20201769T1 (ru)
HU (1) HUE052039T2 (ru)
IL (1) IL265617B (ru)
IT (1) IT201600098338A1 (ru)
LT (1) LT3518927T (ru)
PT (1) PT3518927T (ru)
RS (1) RS61109B1 (ru)
RU (1) RU2765102C2 (ru)
SI (1) SI3518927T1 (ru)
WO (1) WO2018060947A1 (ru)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54125630A (en) * 1978-02-22 1979-09-29 Nippon Zoki Pharmaceutical Co Novel propanone derivative*its manufacture and medical composition containing it as active component
DE2842091A1 (de) * 1978-09-27 1980-04-10 Dow Chemical Co Verfahren zur inaktivierung behuellter viren
JPS5549317A (en) * 1978-10-02 1980-04-09 Dow Chemical Co Control of virus surrounded with phenylketones
US4931473A (en) * 1989-02-15 1990-06-05 Richardson-Vicks Inc. Anesthetic oral compositions
WO2001028550A1 (en) 1999-10-15 2001-04-26 Mayo Foundation For Medical Education And Research Topical anesthetics useful for treating cancer, autoimmune diseases and ischemia
US8318812B2 (en) * 2006-06-02 2012-11-27 The Ohio State University Research Foundation Therapeutic agents for the treatment of lymphoid malignancies
FR2902789A1 (fr) * 2006-06-21 2007-12-28 Genfit Sa Derives de 1,3-diphenylpropane substitues, preparations et utilisations
WO2009045443A2 (en) * 2007-10-02 2009-04-09 The University Of Rochester Methods and compositions related to synergistic responses to oncogenic mutations
US8309768B2 (en) * 2010-11-29 2012-11-13 The Ohio State University Research Foundation FTY720-derived anticancer agents

Also Published As

Publication number Publication date
JP7016370B2 (ja) 2022-02-21
RS61109B1 (sr) 2020-12-31
JP2019529576A (ja) 2019-10-17
BR112019006565A2 (pt) 2019-07-02
RU2019113064A (ru) 2020-10-30
US20200039946A1 (en) 2020-02-06
EP3518927B1 (en) 2020-08-12
WO2018060947A1 (en) 2018-04-05
ES2830749T3 (es) 2021-06-04
CN110035753B (zh) 2022-08-05
RU2765102C2 (ru) 2022-01-25
LT3518927T (lt) 2021-01-25
HUE052039T2 (hu) 2021-04-28
IL265617A (en) 2019-05-30
US11345673B2 (en) 2022-05-31
DK3518927T3 (da) 2020-11-09
AU2017335421A1 (en) 2019-05-16
CA3038008A1 (en) 2018-04-05
EP3518927B9 (en) 2021-04-07
IL265617B (en) 2022-01-01
PT3518927T (pt) 2020-11-12
IT201600098338A1 (it) 2018-03-30
EP3518927A1 (en) 2019-08-07
SI3518927T1 (sl) 2021-01-29
CN110035753A (zh) 2019-07-19
HRP20201769T1 (hr) 2021-03-19

Similar Documents

Publication Publication Date Title
BR112018068177A2 (ru)
BR112019008105A2 (ru)
BR112019009203A2 (ru)
RU2019113064A3 (ru)
JP1586192S (ru)
RU2016148279A3 (ru)
JP1565487S (ru)
CN303591569S (ru)
CN303591070S (ru)
CN303579969S (ru)
CN303576182S (ru)
CN303553163S (ru)
CN303542335S (ru)
CN303539291S (ru)
CN303552136S (ru)
CN303537446S (ru)
CN303633627S (ru)
CN303539000S (ru)
CN303551829S (ru)
CN303539221S (ru)
CN303593953S (ru)
CN303584788S (ru)
CN303592714S (ru)
CN303539498S (ru)
CN303552560S (ru)